Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018 :Transparency Market Research

REPORT DESCRIPTION
Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3
Billion Globally in 2018
According to a new market research report published by Transparency Market Research
“Artificial Vital Organs and Medical Bionics Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast, 2012 - 2018," in 2011, the artificial vital organs
and medical bionics market was valued at USD 17.5 billion and it is expected to grow at a
CAGR of 9.2% from 2012 to 2018, to reach an estimated value of USD 32.3 billion in 2018.
An artificial organ is a man-made device, which is integrated or implanted into the patient,
to replace an original diseased organ and restore its specific function. Medical bionics is the
study of application of mechanics and electronics to replace a limb or other part of a
functional organ that is mechanically powered. With rapid development in healthcare
technology, organ transplantation has evolved as a common surgical practice. With years of
extensive research and development in the field of medical devices and related
technological innovations, artificial vital organs and medical bionics are successfully
established as viable alternatives for the replacement of donor organs as the latter are not
Transparency Market Research
Artificial Vital Organs and
Medical Bionics Market -
Global Industry Analysis,
Size, Share, Growth,
Trends and Forecast 2012 -
2018
Single User License: US $ 4595
Multi User License: US $ 7595
Corporate User License: US $ 10595
Buy Now
Request Sample
Published Date: June 2013
139 Pages Report

Browse Report : Artificial Vital Organs and Medical Bionics Market
able to keep pace with an increase in demand for efficient rehabilitation of the physically
challenged.
The global artificial vital organs market is segmented into artificial heart, kidney, lungs, liver
and pancreas markets. The market for artificial vital organs is led by the artificial kidney
segment, in terms of revenue. Increase in prevalence of renal disorders and acute renal
failure due to the sedentary lifestyle is a major driver for this market. Increase in the
prevalence of cardiovascular diseases leading to acute cardiac failure has led to a growing
need for heart replacement. Also, the number of patients awaiting transplant are far more
than the availability of donor organs and this has led to an increase in the demand for total
artificial heart (TAH). The market for total artificial heart is expected to grow at a CAGR of
more than 9% from 2012 to 2018.
The medical bionics market is categorized into ear bionics (cochlear implants), vision
bionics, exoskeletons, bionic limbs, brain bionics and cardiac bionics. High prevalence of
occupation and age-related disabilities demands novel methods of patient rehabilitation to
offer a better life for such patients. The market for exoskeletons is expected to emerge as
the fastest growing segment, at a CAGR of over 15% from 2012 to 2018.
Geographically, North America leads the market for artificial vital organs and medical
bionics. Aging of the baby boomer population and the corresponding rise in prevalence of
acute cases of cardiovascular diseases, renal diseases and respiratory disorders, and the
increase in prevalence of age-related disorders and occupation-related disabilities are the
major drivers for the growth in demand for artificial organs in North America. However,
improvement in healthcare expenditure and healthcare infrastructure and rising scope of
medical tourism will increase the market share of Asia-Pacific in the future.
The key players in the artificial vital organs and medical bionics market include Abbott
Diabetes Care, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter International, Inc.,
Gambro AB, Medtronic, Inc., Nikkiso Co., Ltd., SynCardia Systems, Inc., Ossur Hf,
WorldHeart Corporation, Ekso Bionics, Touch Bionics, Ottobock Healthcare Gmbh, Second
Sight Medical Products, Inc. and others.
The global artificial vital organs and medical bionics market is segmented as follows:
Artificial Vital Organs and Medical Bionics Market, by Product Types
 Artificial Vital Organs Market
o Artificial Heart
 Total Artificial Heart
o Artificial Kidney
 Hemodialysis Machines

o Artificial Liver
o Artificial Pancreas
 Insulin Pumps
o Artificial Lungs
 Heart-Lung Bypass Machine
 Oxygenators
 Medical Bionics Market
o Ear Bionics (Cochlear implants)
o Vision Bionics
o Exoskeletons
o Bionic Limbs
 Bionic Leg
 Bionic Hand
o Brain Bionics
 Spinal Cord Stimulators
 Deep Brain Stimulators
 Vagus Nerve Stimulators
o Cardiac Bionics
 Ventricular Assist Devices (VAD)
 Left Ventricular Assist Device (LVAD)
 Right Ventricular Assist Device (RVAD)
 Heart Valves
 Mechanical Heart Valves
 Biological Tissue Valves
 Transcatheter Heart Valves
Artificial Vital Organs and Medical Bionics Market, by Geography
 North America

 Europe
 Asia-Pacific
 Rest of the World (RoW)
Browse the full report at http://www.transparencymarketresearch.com/artificial-
vital-organs-medical-bionics.html
TABLE OF CONTENTS
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
Chapter 3 Global Artificial Vital Organs and Medical Bionics Market Overview
3.1 Introduction
3.2 Market Trends and Future Outlook
3.3 Market Drivers
3.3.1 Increase in Prevalence of Organ Failure and Disabilities
3.3.2 Increase in the Number of Patients for Organ Transplant and Lack Of Donor
Organs
3.4 Market Restraints
3.4.1 Criticism Associated with Artificial Organ Transplant
3.4.2 High Cost Involved in Development of Artificial Organs and Medical Bionics
3.5 Market Opportunities
3.5.1 Scope Of Artificial Organs in Therapeutics
3.6 Porter’s Five Force Analysis: Global Artificial Vital Organs & Medical Bionics Market
3.6.1 Bargaining Power of Suppliers

3.6.2 Bargaining Power of Buyers
3.6.3 Threat from Substitutes
3.6.4 Threat of New Entrants
3.6.5 Degree of Competitive Rivalry
3.7 Market Attractiveness Analysis: Global Artificial Vital Organs and Medical Bionics Market,
By Geography
Chapter 4 Global Artificial Vital Organs and Medical Bionics Market, By Product
Type
4.1 Overview
4.2 Artificial Vital Organs Market
4.2.1 Artificial Heart
4.2.1.1 Total Artificial Heart (TAH)
4.2.2 Artificial Kidney
4.2.2.1 Hemodialysis Machines
4.2.3 Artificial Liver
4.2.4 Artificial Pancreas
4.2.4.1 Insulin Pumps
4.2.5 Artificial Lungs
4.2.5.1 Heart-Lung Bypass Machines
4.2.5.2 Oxygenators
4.3 Bionics Market
4.3.1 Ear Bionics (Cochlear Implants)
4.3.2 Vision Bionics
4.3.3 Exoskeletons
4.3.4 Bionic Limbs
4.3.4.1 Bionic Leg
4.3.4.2 Bionic Hand

4.3.5 Brain Bionics
4.3.5.1 Spinal Cord Stimulators
4.3.5.2 Deep Brain Stimulators
4.3.5.3 Vagus Nerve Stimulators
4.3.6 Cardiac Bionics
4.3.6.1 Ventricular Assist Device (VAD)
4.3.6.2 Left Ventricular Assist Device (LVAD)
4.3.6.3 Right Ventricular Assist Device (RVAD)
4.3.6.4 Heart Valves
4.3.6.4.1 Mechanical Heart Valves
4.3.6.4.2 Biological Tissue Valves
4.3.6.4.3 Transcatheter Heart Valves
Chapter 5 Global Artificial Vital Organs and Medical Bionics Market, By Geography
5.1 Introduction
5.2 North America
5.2.1 North America Artificial Vital Organs and Medical Bionics Market, Size and
Forecast, 2010 – 2018 (USD Million)
5.3 Europe
5.3.1 Europe Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010
– 2018 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Artificial Vital Organs and Medical Bionics Market, Size and Forecast,
2010 – 2018 (USD Million)
5.5 Rest of the World (Row)

5.5.1 Row Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 –
2018 (USD Million)
Chapter 6 Competitive Landscape
6.1 Current Market Scenario and Pipeline Snapshot
Chapter 7 Recommendations
7.1 Market Strategy for Success
7.2 Barriers to be Considered
7.2.1 Financial Constraints
7.2.2 Regulatory Approvals
Chapter 8 Company Profiles
8.1 Abbott Diabetes Care, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Strategic Overview
8.1.5 Recent Developments
8.2 Abiomed, Inc.
8.3 Asahi Kasei Medical Co., Ltd.

8.4 Baxter International, Inc.
8.5 Cyberonics, Inc.
8.6 Edwards Lifesciences Corporation
8.7 Ekso Bionics

8.8 F. Hoffmann-La Roche Ltd
8.9 Fresenius Medical Care AG & Co. Kgaa
8.10 Gambro AB
8.11 Iwalk, Inc.

8.12 Jarvik Heart, Inc.
8.13 Medtronic, Inc.
8.14 Micromed Cardiovascular, Inc.
8.15 Nikkiso Co., Ltd.

8.16 Ossur Hf
8.17 Ottobock Healthcare Gmbh
8.18 Second Sight Medical Products, Inc.
8.19 Syncardia Systems, Inc.
8.20 Thoratec Corporation

8.21 Touch Bionics, Inc.
8.22 Vital Therapies, Inc.
8.23 Worldheart Corporation
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018 :Transparency Market Research

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Empfohlen

Empfohlen (20)

Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018 :Transparency Market Research